Viral FGARAT Homolog ORF75 of Rhesus Monkey Rhadinovirus Effects Proteasomal Degradation of the ND10 Components SP100 and PML

J Virol. 2016 Aug 12;90(17):8013-28. doi: 10.1128/JVI.01181-16. Print 2016 Sep 1.

Abstract

Nuclear domain 10 (ND10) components restrict herpesviral infection, and herpesviruses antagonize this restriction by a variety of strategies, including degradation or relocalization of ND10 proteins. The rhesus monkey rhadinovirus (RRV) shares many key biological features with the closely related Kaposi's sarcoma-associated herpesvirus (KSHV; human herpesvirus 8) and readily infects cells of both human and rhesus monkey origin. We used the clustered regularly interspaced short palindromic repeat-Cas9 (CRISPR-Cas9) technique to generate knockout (ko) cells for each of the four ND10 components, PML, SP100, DAXX, and ATRX. These ko cells were analyzed with regard to permissiveness for RRV infection. In addition, we analyzed the fate of the individual ND10 components in infected cells by immunofluorescence and Western blotting. Knockout of the ND10 component DAXX markedly increased RRV infection, while knockout of PML or SP100 had a less pronounced effect. In line with these observations, RRV infection resulted in rapid degradation of SP100, followed by degradation of PML and the loss of ND10 structures, whereas the protein levels of ATRX and DAXX remained constant. Notably, inhibition of the proteasome but not inhibition of de novo gene expression prevented the loss of SP100 and PML in cells that did not support lytic replication, compatible with proteasomal degradation of these ND10 components through the action of a viral tegument protein. Expression of the RRV FGARAT homolog ORF75 was sufficient to effect the loss of SP100 and PML in transfected or transduced cells, implicating ORF75 as the viral effector protein.

Importance: Our findings highlight the antiviral role of ND10 and its individual components and further establish the viral FGARAT homologs of the gammaherpesviruses to be important viral effectors that counteract ND10-instituted intrinsic immunity. Surprisingly, even closely related viruses like KSHV and RRV evolved to use different strategies to evade ND10-mediated restriction. RRV first targets SP100 for degradation and then targets PML with a delayed kinetic, a strategy which clearly differs from that of other gammaherpesviruses. Despite efficient degradation of these two major ND10 components, RRV is still restricted by DAXX, another abundant ND10 component, as evidenced by a marked increase in RRV infection and replication upon knockout of DAXX. Taken together, our findings substantiate PML, SP100, and DAXX as key antiviral proteins, in that the first two are targeted for degradation by RRV and the last one still potently restricts replication of RRV.

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism
  • Antigens, Nuclear / metabolism*
  • Autoantigens / metabolism*
  • Blotting, Western
  • Cell Line
  • Co-Repressor Proteins
  • DNA Helicases / metabolism
  • Host-Pathogen Interactions*
  • Humans
  • Microscopy, Fluorescence
  • Molecular Chaperones
  • Nuclear Proteins / metabolism*
  • Promyelocytic Leukemia Protein / metabolism*
  • Proteasome Endopeptidase Complex / metabolism*
  • Proteolysis
  • Rhadinovirus / pathogenicity*
  • Viral Structural Proteins / metabolism*
  • X-linked Nuclear Protein

Substances

  • Adaptor Proteins, Signal Transducing
  • Antigens, Nuclear
  • Autoantigens
  • CALCOCO2 protein, human
  • Co-Repressor Proteins
  • DAXX protein, human
  • Molecular Chaperones
  • Nuclear Proteins
  • Promyelocytic Leukemia Protein
  • Viral Structural Proteins
  • SP100 protein, human
  • PML protein, human
  • Proteasome Endopeptidase Complex
  • DNA Helicases
  • ATRX protein, human
  • X-linked Nuclear Protein

Grants and funding

This work, including the efforts of Armin Ensser, was funded by Bavaria California Technology Center (BaCaTeC; A8), by Deutsche Forschungsgemeinschaft (DFG; SFB796 project B1), and by Wilhelm Sander-Stiftung (2013.105.1). This work, including the efforts of Alexander Siegfried Hahn, was funded by IZKF Erlangen (J44), by Deutsche Forschungsgemeinschaft (DFG) (Ha 6013/1-1), and by Deutsches Primatenzentrum (DPZ). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.